AMRN Stock Summary and Trading Ideas (Amarin PLC - American Depositary Shares Each Representing One Ordinary Share | NASDAQ:AMRN)

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Amarin PLC - American Depositary Shares Each Representing One Ordinary Share trades on the NASDAQ stock market under the symbol AMRN.

As of April 24, 2024, AMRN stock price declined to $0.88 with 653,691 million shares trading.

AMRN has a beta of 1.86, meaning it tends to be more sensitive to market movements. AMRN has a correlation of 0.12 to the broad based SPY ETF.

AMRN has a market cap of $358.19 million. This is considered a Small Cap stock.

Last quarter Amarin PLC - American Depositary Shares Each Representing One Ordinary Share reported $75 million in Revenue and $.00 earnings per share. This beat revenue expectation by $11 million and exceeded earnings estimates by $.03.

In the last 3 years, AMRN stock traded as high as $5.97 and as low as $.65.

The top ETF exchange traded funds that AMRN belongs to (by Net Assets): SPDW, GWX, APIE, QQQS, BIB.

AMRN has underperformed the market in the last year with a price return of -34.9% while the SPY ETF gained +24.2%. AMRN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -27.4% and -17.1%, respectively, while the SPY returned +4.6% and -2.7%, respectively.

AMRN support price is $.85 and resistance is $.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AMRN stock will trade within this expected range on the day.